Sectors
DRMA
Dermata Therapeutics, Inc.
1.29
2 x 0.94
2 x 1.65
bid
ask
-
0.05
3.73%
2 @ 06:52 PM
1.31 +0.02 (1.55%)
| Ytd | -44.40% | |
| 1y | -77.53% |
1.27
day range
1.33
0.95
52 week range
6.22
| Open | 1.30 | Prev Close | 1.34 | Low | 1.27 | High | 1.33 | Mkt Cap | 6.39M |
| Vol | 61.67K | Avg Vol | 743.35K | EPS | -4.20 | P/E | N/A | Forward P/E | -0.32 |
| Beta | 0.79 | Short Ratio | 0.52 | Inst. Own | 0.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.31 | 200-d Avg | 1.64 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 3.01M | ||
| Research and Development Expense | 212.56K | ||
| Selling, General and Administrative Expense | 2.80M | ||
| Operating Income | -3.01M | ||
| Net Income | -2.97M | ||
| Net Income Common Stock | -2.97M | ||
| Net Income Common Stock (USD) | -2.97M | ||
| Consolidated Income | -2.97M | ||
| Earnings per Basic Share | -0.74 | ||
| Earnings per Basic Share (USD) | -0.74 | ||
| Earnings per Diluted Share | -0.74 | ||
| Earning Before Interest & Taxes (EBIT) | -2.97M | ||
| Earning Before Interest & Taxes (USD) | -2.97M | ||
| Weighted Average Shares | 4.02M | ||
| Weighted Average Shares Diluted | 4.02M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.41M | ||
| Cash and Equivalents (USD) | 4.41M | ||
| Current Assets | 5.16M | ||
| Property, Plant & Equipment Net | 129.37K | ||
| Total Assets | 5.32M | ||
| Total Liabilities | 1.83M | ||
| Accumulated Retained Earnings (Deficit) | -78.05M | ||
| Shareholders Equity | 3.49M | ||
| Shareholders Equity (USD) | 3.49M | ||
| Assets Non-Current | 164.70K | ||
| Inventory | 149.73K | ||
| Trade and Non-Trade Payables | 1.12M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -323.00 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.53M | ||
| Issuance (Purchase) of Equity Shares | -323.00 | ||
| Net Cash Flow from Operations | -2.42M | ||
| Share Based Compensation | 41.78K | ||